My primary research interest is in improving the identification and management of patients with a hereditary risk of cancer. I’m also interested in chemoprevention studies in this high-risk population. Additionally I’m the primary investigator for a multi-site investigator-initiated clinical trial for treatment of c-kit mutated melanomas.
I serve as an associate professor of clinical internal medicine for The Ohio State University College of Medicine, helping to train the next generation of future physicians. I love being affiliated with the OSUCCC – James. This is a world-class facility filled with experts in their particular field of cancer treatment and research. Together we collaborate as we care for our patients and look for the next big breakthrough in cancer research.
University of Texas Medical School at Houston
University of Alabama Hospitals
7/1/2000 - 6/30/2002
Specialties and conditions I treat
- Medical Oncology
Locations where I practice
Martha Morehouse Medical Plaza
More about my work
University of Michigan Hospitals
7/1/2002 - 6/30/2005
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/17, Dr. Jeter has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Pfizer, Inc.